GB1131007A - Improvements in or relating to aqueous solutions of oxytetracycline - Google Patents
Improvements in or relating to aqueous solutions of oxytetracyclineInfo
- Publication number
- GB1131007A GB1131007A GB22620/67A GB2262067A GB1131007A GB 1131007 A GB1131007 A GB 1131007A GB 22620/67 A GB22620/67 A GB 22620/67A GB 2262067 A GB2262067 A GB 2262067A GB 1131007 A GB1131007 A GB 1131007A
- Authority
- GB
- United Kingdom
- Prior art keywords
- oxytetracycline
- magnesium
- aqueous solutions
- sodium
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000004100 Oxytetracycline Substances 0.000 title abstract 4
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 title abstract 4
- 229960000625 oxytetracycline Drugs 0.000 title abstract 4
- 235000019366 oxytetracycline Nutrition 0.000 title abstract 4
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 title abstract 4
- 239000007864 aqueous solution Substances 0.000 title abstract 2
- 150000002681 magnesium compounds Chemical class 0.000 abstract 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- -1 chloride or sulphate Chemical class 0.000 abstract 1
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 abstract 1
- 229910001425 magnesium ion Inorganic materials 0.000 abstract 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 abstract 1
- 239000000395 magnesium oxide Substances 0.000 abstract 1
- 159000000003 magnesium salts Chemical class 0.000 abstract 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 abstract 1
- 239000002609 medium Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 abstract 1
- VYGBQXDNOUHIBZ-UHFFFAOYSA-L sodium formaldehyde sulphoxylate Chemical compound [Na+].[Na+].O=C.[O-]S[O-] VYGBQXDNOUHIBZ-UHFFFAOYSA-L 0.000 abstract 1
- 239000004296 sodium metabisulphite Substances 0.000 abstract 1
- 235000010262 sodium metabisulphite Nutrition 0.000 abstract 1
- 235000010265 sodium sulphite Nutrition 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
- A61K31/79—Polymers of vinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL6607516A NL6607516A (enExample) | 1966-05-31 | 1966-05-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1131007A true GB1131007A (en) | 1968-10-16 |
Family
ID=19796753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB22620/67A Expired GB1131007A (en) | 1966-05-31 | 1967-05-16 | Improvements in or relating to aqueous solutions of oxytetracycline |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US3557280A (enExample) |
| JP (1) | JPS5010373B1 (enExample) |
| AT (1) | AT272522B (enExample) |
| BE (1) | BE699091A (enExample) |
| CH (1) | CH490087A (enExample) |
| CS (1) | CS151454B2 (enExample) |
| DE (1) | DE1617576C3 (enExample) |
| DK (1) | DK117587B (enExample) |
| ES (1) | ES340956A1 (enExample) |
| FI (1) | FI43622B (enExample) |
| FR (1) | FR5953M (enExample) |
| GB (1) | GB1131007A (enExample) |
| GR (1) | GR33861B (enExample) |
| IL (1) | IL28009A (enExample) |
| IT (1) | IT1140250B (enExample) |
| LU (1) | LU53788A1 (enExample) |
| MY (1) | MY7100015A (enExample) |
| NL (1) | NL6607516A (enExample) |
| NO (1) | NO126298B (enExample) |
| SE (1) | SE354417B (enExample) |
| SU (1) | SU510986A3 (enExample) |
| YU (1) | YU31326B (enExample) |
Families Citing this family (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5418330B2 (enExample) * | 1973-03-16 | 1979-07-06 | ||
| US3966905A (en) * | 1973-05-29 | 1976-06-29 | Barnes-Hind Pharmaceuticals, Inc. | Stabilized catechol amine solutions |
| US3929989A (en) * | 1974-06-14 | 1975-12-30 | Wendt Lab Inc | Stable suspension of calcium-magnesium oxytetracycline for intrauterine administration in treatment of bovine metritis |
| GB1538903A (en) * | 1975-04-11 | 1979-01-24 | Nelson Res & Dev | Carrier for a topically applied physiologically active agent or cosmetic agent |
| US4018889A (en) * | 1976-01-02 | 1977-04-19 | Pfizer Inc. | Oxytetracycline compositions |
| DE2602363C2 (de) * | 1976-01-22 | 1984-04-12 | Bayer Ag, 5090 Leverkusen | Wäßrige, injizierbare Niclofolan- Formulierungen |
| GB1592053A (en) * | 1976-12-16 | 1981-07-01 | Norbrook Lab Ltd | Oxytetracycline compositions |
| US4213963A (en) * | 1978-12-14 | 1980-07-22 | Janssen Pharmaceutica N.V. | Fluspirilene-containing compositions |
| US4259331A (en) * | 1979-04-16 | 1981-03-31 | Pfizer Inc. | Oxytetracycline compositions |
| US4399127A (en) * | 1980-04-10 | 1983-08-16 | Diamond Shamrock Corporation | Injectable oxytetracycline compositions |
| US4386083A (en) * | 1980-04-10 | 1983-05-31 | Walter Hacke | Injectable oxytetracycline compositions |
| IE74244B1 (en) * | 1985-10-01 | 1997-07-16 | Bimeda Res Dev Ltd | A process for preparing an antibiotic composition |
| US5071643A (en) * | 1986-10-17 | 1991-12-10 | R. P. Scherer Corporation | Solvent system enhancing the solubility of pharmaceuticals for encapsulation |
| US6756365B2 (en) * | 1991-11-06 | 2004-06-29 | Trustees Of Tufts College | Reducing tetracycline resistance in living cells |
| EP0626171A1 (de) * | 1993-05-26 | 1994-11-30 | Winfried Dörnhöfer | Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere |
| US6383515B2 (en) | 1999-05-28 | 2002-05-07 | Sawyer Maryjean | Solvent system for enhancing solubility |
| US6500812B2 (en) | 1999-09-14 | 2002-12-31 | Paratek Pharmaceuticals, Inc. | 13-substituted methacycline compounds |
| CA2383364C (en) | 1999-09-14 | 2009-11-17 | Trustees Of Tufts College | Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| US8106225B2 (en) * | 1999-09-14 | 2012-01-31 | Trustees Of Tufts College | Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| US6849615B2 (en) | 1999-09-14 | 2005-02-01 | Paratek Pharmaceuticals, Inc. | 13-substituted methacycline compounds |
| AU3105801A (en) * | 2000-01-24 | 2001-07-31 | Trustees Of Tufts College | Tetracycline compounds for treatment of cryptosporidium parvum related disorders |
| ES2288945T3 (es) * | 2000-03-31 | 2008-02-01 | Trustees Of Tufts College | Compuestos de tetraciclina 7 y 9-carbamato, urea, tiourea, tiocarbamato y heteroaril-amino sustituidos. |
| EP2308863A1 (en) | 2000-05-15 | 2011-04-13 | Paratek Pharmaceuticals, Inc. | 7-substituted fused ring tetracycline compounds |
| US20020132798A1 (en) * | 2000-06-16 | 2002-09-19 | Nelson Mark L. | 7-phenyl-substituted tetracycline compounds |
| AU2001268475A1 (en) * | 2000-06-16 | 2002-01-02 | Trustees Of Tufts College | 7-phenyl-substituted tetracycline compounds |
| US20040224927A1 (en) | 2000-06-16 | 2004-11-11 | Trustees Of Tufts College | 7-N-substituted phenyl tetracycline compounds |
| US20050143353A1 (en) * | 2000-07-07 | 2005-06-30 | Paratek Pharmaceuticals, Inc. | 13-Substituted methacycline compounds |
| US7094806B2 (en) | 2000-07-07 | 2006-08-22 | Trustees Of Tufts College | 7, 8 and 9-substituted tetracycline compounds |
| EP3461808A1 (en) * | 2000-07-07 | 2019-04-03 | Trustees of Tufts College | 9-substituted minocycline compounds |
| WO2002004407A2 (en) * | 2000-07-07 | 2002-01-17 | Trustees Of Tufts College | 7-substituted tetracycline compounds |
| HRP20030092A2 (en) | 2000-07-07 | 2004-06-30 | Tufts College | 13-substituted methacycline compounds |
| EP1303479B1 (en) | 2000-07-07 | 2011-04-06 | Trustees Of Tufts College | 7-, 8- and 9-substituted tetracycline compounds |
| CZ20032780A3 (cs) * | 2001-03-13 | 2004-01-14 | Paratek Pharmaceuticals, Inc. | 7,9- Substituované tetracyklinové sloučeniny |
| AU2002250331A1 (en) * | 2001-03-13 | 2002-09-24 | Paratek Pharmaceuticals, Inc. | 7-pyrollyl tetracycline compounds and methods of use thereof |
| JP2005504722A (ja) | 2001-03-14 | 2005-02-17 | パラテック ファーマシューティカルズ インコーポレイテッド | 相乗的抗真菌薬剤としての置換テトラサイクリン化合物 |
| EP1379255A2 (en) * | 2001-03-14 | 2004-01-14 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds as antifungal agents |
| US8088820B2 (en) * | 2001-04-24 | 2012-01-03 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for the treatment of malaria |
| AU2002254714C1 (en) | 2001-04-24 | 2010-01-07 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for the treatment of malaria |
| EP2311799A1 (en) | 2002-01-08 | 2011-04-20 | Paratek Pharmaceuticals, Inc. | 4-dedimethylamino tetracycline compounds |
| AU2003220123B2 (en) | 2002-03-08 | 2009-05-07 | Paratek Pharmaceuticals, Inc. | Amino-methyl substituted tetracycline compounds |
| IL164180A0 (en) | 2002-03-21 | 2005-12-18 | Paratek Pharm Innc | Substituted tetracycline compounds |
| EP1534300A4 (en) | 2002-07-12 | 2008-04-23 | Paratek Pharm Innc | TETRACYCLINE COMPOUNDS SUBSTITUTED IN 3, 10, AND 12A |
| EP1556007A4 (en) | 2002-10-24 | 2008-12-17 | Paratek Pharm Innc | SUBSTITUTED TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF MALARIA |
| EP1605916A4 (en) * | 2003-02-12 | 2012-02-22 | R & P Korea Co Ltd | SOLUBENT SOLVENT SYSTEM WITH SOLUBLE PEEL WITH IMPROVED ELUTION RATE |
| US20060287283A1 (en) * | 2003-07-09 | 2006-12-21 | Paratek Pharmaceuticals, Inc. | Prodrugs of 9-aminomethyl tetracycline compounds |
| EP2319828A3 (en) | 2003-07-09 | 2011-07-06 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
| US20050137174A1 (en) | 2003-07-09 | 2005-06-23 | Paratek Pharmaceuticals, Inc. | Prodrugs of 9-aminomethyl tetracycline compounds |
| EP2332904A3 (en) | 2004-01-15 | 2012-04-11 | Paratek Pharmaceuticals, Inc. | Derivatives of tetracycline compounds |
| TWI261038B (en) * | 2004-08-11 | 2006-09-01 | Bo-Cheng Chen | Bicycle gear-shifting handgrip |
| EP2284151A3 (en) | 2004-10-25 | 2011-09-21 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
| AU2005299294B2 (en) | 2004-10-25 | 2012-06-07 | Paratek Pharmaceuticals, Inc. | 4-aminotetracyclines and methods of use thereof |
| CA2597212A1 (en) | 2005-02-04 | 2006-08-10 | Paratek Pharmaceuticals, Inc. | 11a, 12-derivatives of tetracycline compounds |
| DE102005012595A1 (de) * | 2005-03-18 | 2006-09-21 | Lanxess Deutschland Gmbh | Herstellung von Tri(chlorpropyl)phosphat |
| WO2007014154A2 (en) * | 2005-07-21 | 2007-02-01 | Paratek Pharmaceuticals, Inc. | 10-substituted tetracyclines and methods of use thereof |
| CA2622704A1 (en) * | 2005-09-19 | 2007-03-29 | Albemarle Corporation | Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses |
| JP2009524675A (ja) * | 2006-01-24 | 2009-07-02 | パラテック ファーマシューティカルズ インコーポレイテッド | テトラサイクリンの経口バイオアベイラビリティーを増加する方法 |
| CA2649221A1 (en) * | 2006-04-17 | 2007-10-25 | Evgeny Tsiperman | Isolation of tetracycline derivatives |
| CA2649075A1 (en) * | 2006-04-24 | 2007-11-08 | Teva Pharmaceutical Industries Ltd. | Tigeycline crystalline forms and processes for preparation thereof |
| US8198470B2 (en) * | 2006-04-24 | 2012-06-12 | Teva Pharmaceutical Industries Ltd. | Crystalline form II of tigecycline and processes for preparation thereof |
| WO2007133798A2 (en) * | 2006-05-15 | 2007-11-22 | Paratek Pharmaceuticals, Inc. | Methods of regulating expression of genes or of gene products using substituted tetracycline compounds |
| US8440646B1 (en) | 2006-10-11 | 2013-05-14 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for treatment of Bacillus anthracis infections |
| PT2120963T (pt) | 2006-12-21 | 2018-12-17 | Paratek Pharm Innc | Compostos tetraciclina substituídos para tratamento de distúrbios inflamatórios da pele |
| EP3045449A1 (en) | 2006-12-21 | 2016-07-20 | Paratek Pharmaceuticals, Inc. | Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections |
| EP2144614A1 (en) * | 2007-04-12 | 2010-01-20 | Paratek Pharmaceuticals, Inc. | Methods for treating spinal muscular atrophy using tetracycline compounds |
| AU2008246119A1 (en) | 2007-04-27 | 2008-11-06 | Paratek Pharmaceuticals, Inc. | Methods for synthesizing and purifying aminoalkyl tetracycline compounds |
| US9522872B2 (en) | 2007-07-06 | 2016-12-20 | Paratek Pharmaceuticals, Inc. | Methods for synthesizing substituted tetracycline compounds |
| RU2010140682A (ru) | 2008-03-05 | 2012-04-10 | Пэрэтек Фамэсьютикэлс, Инк. (US) | Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство |
| PT2271348T (pt) | 2008-03-28 | 2018-04-16 | Paratek Pharm Innc | Formulação de comprimido oral de composto de tetraciclina |
| AU2009236631A1 (en) * | 2008-04-14 | 2009-10-22 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
| TWI585071B (zh) | 2008-05-19 | 2017-06-01 | 派洛泰克藥物股份有限公司 | 四環素化合物之甲苯磺酸鹽及同素異形體 |
| US9629809B2 (en) | 2008-07-21 | 2017-04-25 | Si Group, Inc. | High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms |
| CN102099017A (zh) | 2008-07-21 | 2011-06-15 | 雅宝公司 | 高含量布洛芬钠颗粒、其制备及其在制备非泡腾固体剂型中的用途 |
| MX2011002780A (es) * | 2008-09-19 | 2011-04-27 | Paratek Pharm Innc | Compuestos de tetraciclina para el tratamiento de artritis reumatoide y metodos relacionados de tratamiento. |
| CA2758322C (en) | 2009-04-10 | 2019-04-02 | Tufts Medical Center, Inc. | Par-1 activation by metalloproteinase-1 (mmp-1) |
| ES2985493T3 (es) | 2011-05-12 | 2024-11-06 | Almirall Llc | Composición farmacéutica para administración oral que comprende sales cristalinas de amida del ácido (4S,4aS,5aR,12aS)-4-dimetilamino-3,10,12,12a-tetrahidroxi-7-[(metoxi(metil)amino)-metil]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahidro-naftacen-2-carboxílico |
| EP3534908B1 (en) | 2016-11-01 | 2025-07-09 | Paratek Pharmaceuticals, Inc. | 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (cabp) |
| BR112020000968A2 (pt) | 2017-07-21 | 2020-07-14 | Almirall, Llc | tratamento de lesões não inflamatórias |
-
1966
- 1966-05-31 NL NL6607516A patent/NL6607516A/xx unknown
- 1966-11-08 FR FR82837A patent/FR5953M/fr not_active Expired
-
1967
- 1967-05-16 GB GB22620/67A patent/GB1131007A/en not_active Expired
- 1967-05-18 SE SE06961/67A patent/SE354417B/xx unknown
- 1967-05-18 IL IL28009A patent/IL28009A/en unknown
- 1967-05-22 GR GR670133861A patent/GR33861B/el unknown
- 1967-05-24 ES ES340956A patent/ES340956A1/es not_active Expired
- 1967-05-25 SU SU1158241A patent/SU510986A3/ru active
- 1967-05-26 BE BE699091D patent/BE699091A/xx not_active IP Right Cessation
- 1967-05-26 DE DE1617576A patent/DE1617576C3/de not_active Expired
- 1967-05-26 US US641483A patent/US3557280A/en not_active Expired - Lifetime
- 1967-05-30 IT IT37118/67A patent/IT1140250B/it active
- 1967-05-30 AT AT502267A patent/AT272522B/de active
- 1967-05-30 NO NO00168375A patent/NO126298B/no unknown
- 1967-05-30 DK DK282167AA patent/DK117587B/da unknown
- 1967-05-30 FI FI1517/67A patent/FI43622B/fi active
- 1967-05-30 YU YU1086/67A patent/YU31326B/xx unknown
- 1967-05-31 LU LU53788A patent/LU53788A1/xx unknown
- 1967-05-31 JP JP42034292A patent/JPS5010373B1/ja active Pending
- 1967-05-31 CH CH766867A patent/CH490087A/de not_active IP Right Cessation
- 1967-05-31 CS CS3970A patent/CS151454B2/cs unknown
-
1971
- 1971-12-30 MY MY15/71A patent/MY7100015A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES340956A1 (es) | 1968-06-16 |
| NL6607516A (enExample) | 1967-12-01 |
| NO126298B (enExample) | 1973-01-22 |
| IL28009A (en) | 1970-08-19 |
| SU510986A3 (ru) | 1976-04-15 |
| YU31326B (en) | 1973-04-30 |
| CH490087A (de) | 1970-05-15 |
| DE1617576B2 (de) | 1980-04-10 |
| LU53788A1 (enExample) | 1967-07-31 |
| IT1140250B (it) | 1986-09-24 |
| DE1617576C3 (de) | 1980-12-11 |
| AT272522B (de) | 1969-07-10 |
| CS151454B2 (enExample) | 1973-10-19 |
| DK117587B (da) | 1970-05-11 |
| SE354417B (enExample) | 1973-03-12 |
| GR33861B (el) | 1968-02-09 |
| US3557280A (en) | 1971-01-19 |
| FI43622B (enExample) | 1971-02-01 |
| MY7100015A (en) | 1971-12-31 |
| DE1617576A1 (de) | 1972-04-27 |
| FR5953M (enExample) | 1968-04-16 |
| JPS5010373B1 (enExample) | 1975-04-21 |
| BE699091A (enExample) | 1967-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1131007A (en) | Improvements in or relating to aqueous solutions of oxytetracycline | |
| GB1494558A (en) | Oxytetracycline solution for parenteral peroral and local administration and processes for the production thereof | |
| AU576204B2 (en) | Aqueous, injectable solutions of cis-platimum | |
| ES399906A1 (es) | Procedimiento para componer preparados colorantes. | |
| ES450075A1 (es) | Un metodo de preparacion de derivados de bis-triazinilamino-estilbeno. | |
| GB1278117A (en) | Stabilized 2-pam solutions | |
| GB1289693A (enExample) | ||
| GB1331190A (en) | X-ray contrast composition containing barium sulphate | |
| GB1427882A (en) | Oxytetracycline solutions | |
| GB1419933A (en) | Preparation of methylcobalamine | |
| GB1438217A (en) | 1-alkyl-5-nitro-imidaolyl-2-alkyl-pyridyl compounds and process for preparing them | |
| KR860002269A (ko) | 비경구용 액제의 제조방법 | |
| GB1057951A (en) | Improvements in photographic colour processes | |
| GB1361491A (en) | Process for the production of oxytetracycline solutions | |
| GB1532550A (en) | Agent for preventing cold turbidity in beer | |
| GB1291678A (en) | L-dopa and derivatives | |
| GB1222449A (en) | Process for preparing pure human albumin from solutions containing haemopigments | |
| GB1282906A (en) | Alkali metal hypochlorite solutions | |
| GB1135597A (en) | Antacid material | |
| GB1253018A (enExample) | ||
| ES8203016A1 (es) | Un procedimiento para la preparacion de una solucion acuosa inyectable de sales de metales alcalinas de acido canrenoicoy de furosemida. | |
| GB1212522A (en) | Improvements in or relating to the preparation of silver oxide | |
| GB1357926A (en) | Concentrated antacid composition | |
| GB1126537A (en) | Dioxanone derivatives | |
| GB1492837A (en) | Insulin preparations having antidiabetic activity and process for their manufacture |